These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8218262)

  • 21. The substrate specificity of Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase. Analysis of myristic acid analogs containing oxygen, sulfur, double bonds, triple bonds, and/or an aromatic residue.
    Kishore NS; Lu TB; Knoll LJ; Katoh A; Rudnick DA; Mehta PP; Devadas B; Huhn M; Atwood JL; Adams SP
    J Biol Chem; 1991 May; 266(14):8835-55. PubMed ID: 2026598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational design of a new C-myristylamido peptide exerting potent and selective PKC inhibitory activity.
    Zaliani A; Gromo G; Pinori M; Mascagni P
    Drug Des Discov; 1996 Apr; 13(3-4):63-74. PubMed ID: 8874044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myristoylation of protein at a distinct position allows its phosphorylation by protein kinase C.
    Utsumi T; Tokunaga T; Horii J; Edashige K; Utsumi K; Koga D; Ide A
    Arch Biochem Biophys; 1994 Sep; 313(2):337-45. PubMed ID: 8080281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of protein kinase C by a peptide conjugate homologous to a domain of the retroviral protein p15E.
    Gottlieb RA; Kleinerman ES; O'Brian CA; Tsujimoto S; Cianciolo GJ; Lennarz WJ
    J Immunol; 1990 Oct; 145(8):2566-70. PubMed ID: 2212653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A synthetic peptide derived from the non-structural protein 3 of hepatitis C virus serves as a specific substrate for PKC.
    Borowski P; Resch K; Schmitz H; Heiland M
    Biol Chem; 2000 Jan; 381(1):19-27. PubMed ID: 10722046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the calmodulin-binding domain of neuron-specific protein kinase C substrate protein CAP-22/NAP-22. Direct involvement of protein myristoylation in calmodulin-target protein interaction.
    Takasaki A; Hayashi N; Matsubara M; Yamauchi E; Taniguchi H
    J Biol Chem; 1999 Apr; 274(17):11848-53. PubMed ID: 10207003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudosubstrate peptide inhibitors of beta-cell protein kinases: altered selectivity after myristoylation.
    Harris TE; Persaud SJ; Jones PM
    Mol Cell Endocrinol; 1999 Sep; 155(1-2):61-8. PubMed ID: 10580839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies with synthetic peptide substrates derived from the neuronal protein neurogranin reveal structural determinants of potency and selectivity for protein kinase C.
    Chen SJ; Klann E; Gower MC; Powell CM; Sessoms JS; Sweatt JD
    Biochemistry; 1993 Feb; 32(4):1032-9. PubMed ID: 8424932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deletion of the regulatory domain of protein kinase C alpha exposes regions in the hinge and catalytic domains that mediate nuclear targeting.
    James G; Olson E
    J Cell Biol; 1992 Feb; 116(4):863-74. PubMed ID: 1734020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-myristoylation of a peptide substrate for Src converts it into an apparent slow-binding bisubstrate-type inhibitor.
    Ramdas L; Obeyesekere NU; Sun G; McMurray JS; Budde RJ
    J Pept Res; 1999 May; 53(5):569-77. PubMed ID: 10424353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High affinity binding of an N-terminal myristoylated p60src peptide.
    Goddard C; Arnold ST; Felsted RL
    J Biol Chem; 1989 Sep; 264(26):15173-6. PubMed ID: 2504718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for negative control in protein kinase C substrate specificity.
    Ricouart A; Tartar A; Sergheraert C
    Int J Pept Protein Res; 1989 Apr; 33(4):304-7. PubMed ID: 2753600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycyclic aromatic hydrocarbon o-quinones inhibit the activity of the catalytic fragment of protein kinase C.
    Yu D; Kazanietz MG; Harvey RG; Penning TM
    Biochemistry; 2002 Oct; 41(39):11888-94. PubMed ID: 12269833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A synthetic peptide substrate for selective assay of protein kinase C.
    Yasuda I; Kishimoto A; Tanaka S; Tominaga M; Sakurai A; Nishizuka Y
    Biochem Biophys Res Commun; 1990 Feb; 166(3):1220-7. PubMed ID: 1689574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential responses of cyclic GMP-dependent and cyclic AMP-dependent protein kinases to synthetic peptide inhibitors.
    Glass DB
    Biochem J; 1983 Jul; 213(1):159-64. PubMed ID: 6615418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and characterization of protein kinase C from rat brain synaptosome cytoskeleton.
    Tanaka S
    Kobe J Med Sci; 1991 Jun; 37(3):147-61. PubMed ID: 1745042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Michellamine alkaloids inhibit protein kinase C.
    White EL; Chao WR; Ross LJ; Borhani DW; Hobbs PD; Upender V; Dawson MI
    Arch Biochem Biophys; 1999 May; 365(1):25-30. PubMed ID: 10222035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-myristoyl transferase assay using phosphocellulose paper binding.
    King MJ; Sharma RK
    Anal Biochem; 1991 Dec; 199(2):149-53. PubMed ID: 1725948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic peptide analogues differentially alter the binding affinities of cyclic nucleotide dependent protein kinases for nucleotide substrates.
    Bhatnagar D; Glass DB; Roskoski R; Lessor RA; Leonard NJ
    Biochemistry; 1988 Mar; 27(6):1988-94. PubMed ID: 2837278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interaction of myristylated peptides with the catalytic domain of protein kinase C revealed by their sequence palindromy and the identification of a myristyl binding site.
    Zaliani A; Pinori M; Ball HL; DiGregorio G; Cremonesi P; Mascagni P
    Protein Eng; 1998 Sep; 11(9):803-10. PubMed ID: 9796830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.